News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
831,925 Results
Type
Article (85629)
Company Profile (744)
Press Release (745552)
Section
Business (232264)
Career Advice (4106)
Deals (39645)
Drug Delivery (116)
Drug Development (90664)
Employer Resources (194)
FDA (17979)
Job Trends (17274)
News (395604)
Policy (39622)
Tag
Academia (2975)
Alliances (56468)
Alzheimer's disease (1341)
Approvals (17889)
Artificial intelligence (158)
Bankruptcy (394)
Best Places to Work (12530)
Biotechnology (509)
Breast cancer (131)
Cancer (1191)
Cardiovascular disease (113)
Career advice (3513)
Cell therapy (271)
Clinical research (71574)
Collaboration (421)
Compensation (209)
COVID-19 (2804)
C-suite (107)
Data (1167)
Diabetes (168)
Diagnostics (6686)
Earnings (94759)
Employer resources (167)
Events (126863)
Executive appointments (334)
FDA (18560)
Funding (386)
Gene therapy (204)
GLP-1 (697)
Government (5049)
Healthcare (20719)
Infectious disease (2898)
Inflammatory bowel disease (121)
Interviews (807)
IPO (17599)
Job creations (5179)
Job search strategy (2855)
Layoffs (489)
Legal (10044)
Lung cancer (190)
Manufacturing (203)
Medical device (14417)
Medtech (14422)
Mergers & acquisitions (22102)
Metabolic disorders (474)
Neuroscience (1652)
NextGen Class of 2024 (7657)
Non-profit (5065)
Northern California (1532)
Obesity (272)
Opinion (244)
Patents (115)
People (64204)
Pharmaceutical (148)
Phase I (22027)
Phase II (31080)
Phase III (23434)
Pipeline (473)
Postmarket research (3540)
Preclinical (9963)
Radiopharmaceuticals (259)
Rare diseases (248)
Real estate (7373)
Regulatory (25976)
Research institute (2642)
Resumes & cover letters (648)
Southern California (1354)
Startups (4276)
United States (14773)
Vaccines (654)
Weight loss (221)
Date
Today (144)
Last 7 days (705)
Last 30 days (3824)
Last 365 days (38703)
2024 (35593)
2023 (42566)
2022 (53928)
2021 (58726)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Arizona (229)
Asia (49361)
Australia (8699)
California (3571)
Canada (1322)
China (269)
Colorado (160)
Connecticut (175)
Europe (113042)
Florida (481)
Georgia (129)
Illinois (424)
Indiana (216)
Kansas (103)
Maryland (636)
Massachusetts (2885)
Michigan (179)
Minnesota (301)
New Jersey (1016)
New York (1012)
North Carolina (850)
Northern California (1532)
Ohio (149)
Pennsylvania (877)
South America (1647)
Southern California (1354)
Texas (522)
Washington State (404)
There are 831,925 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hemostemix Announces ACP-01 Treatment-Purchase Available with Social Media Campaign Underway
November 25, 2024
·
8 min read
Press Releases
MYND Life Sciences Announces Strategic Debt Reduction and New Board Member Appointment
November 25, 2024
·
3 min read
Press Releases
Defence Announces Closing of Securities for Debenture Financing
November 25, 2024
·
4 min read
Press Releases
Defence Announces Dr. Maxime Parisotto as CSO, Director of Science and Business Development
November 25, 2024
·
3 min read
Press Releases
BioGene Therapeutics Welcomes Dr. Deepak Sampath, PhD. to Its Board of Directors
November 25, 2024
·
6 min read
Press Releases
Neural Therapeutics Undertakes Multiple Initiatives to Defer and Eliminate a Significant Portion of Financial Obligations
November 25, 2024
·
9 min read
Press Releases
PARP Inhibitor Market worth $13.02 Billion by 2031, Coherent Market Insights
November 25, 2024
·
1 min read
Press Releases
Neuropathic Pain Market worth $11.53 Billion by 2030, Coherent Market Insights
November 25, 2024
·
1 min read
Neurodegenerative disease
Biohaven Drug Misses in Phase III for SMA, Will Be Tested in Obesity
While taldefgrobep alfa failed to show improved motor function in spinal muscular atrophy, treated patients saw a marked reduction in body fat. Biohaven plans to launch a Phase II trial in obesity by the end of the year.
November 25, 2024
·
2 min read
·
Tristan Manalac
Alzheimer’s disease
Cassava’s Shares Plunge as Alzheimer’s Drug Fails Phase III
Cassava Sciences has revealed the late-stage clinical failure of controversial Alzheimer’s drug simulfilam. The company had pledged to share the results whether “good, bad or ambiguous.”
November 25, 2024
·
2 min read
·
Annalee Armstrong
1 of 83,193
Next
